Development of HIV Entry Inhibitors Targeted to the Coiled-Coil Regions of gp41
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 269 (3) , 641-646
- https://doi.org/10.1006/bbrc.1999.1972
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The AIDS Epidemic — Considerations for the 21st CenturyNew England Journal of Medicine, 1999
- Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residuesJournal of Molecular Biology, 1998
- Antiviral effect of double and triple drug combinations amongst HIV-infected adultsAIDS, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesisChemistry & Biology, 1996
- Identification of d -Peptide Ligands Through Mirror-Image Phage DisplayScience, 1996
- Multifaceted Consequences of Anti-gp41 Monoclonal Antibody 2F5 Binding to HIV Type 1 VirionsAIDS Research and Human Retroviruses, 1995
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- HIV-1 inhibition by a peptideNature, 1993
- A General Model for the Transmembrane Proteins of HIV and Other RetrovirusesAIDS Research and Human Retroviruses, 1989